MedTrace Logo

Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema Treatment

NCT01257061 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 310

Last updated 2020-07-07

No results posted yet for this study

Summary

Atopic dermatitis is a recurrent pruritic skin disorder which has a significant morbidity and impaired quality of life due specially pruritus and physical visible skin lesions. The propose of this trial is evaluate the effectiveness of clemastine fumarate 1, 0 mg/g + dexamethasone 0, 5 mg/g compared to dexchlorpheniramine maleate 10 mg/g in eczema treatment.

Conditions

Interventions

DRUG

Group 1

Clemastine fumarate 1,0 mg/g + dexamethasone 0,5/g applied 2 times / day at lesion

DRUG

Group 2

Dexchlorpheniramine maleate 10 mg/g applied 2 times / day at lesion

Sponsors & Collaborators

  • EMS

    lead INDUSTRY

Principal Investigators

  • Flavia Addor, MD · Medcin Instituto da Pele

  • Felipe Pinho, MD · EMS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-06
Primary Completion
2013-04-30
Completion
2013-08-02

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01257061 on ClinicalTrials.gov